challenge banner image
FDA Gives Green Light to Mounjaro for Sleep Apnoea
cover image
Free
About Challenge

Mounjaro

Mounjaro Approved To Treat Sleep Apnoea

Mounjaro Australia Cost

πŸ‘‡κ§ΰΌΊβœ¨β—πŽπ…π…πˆπ‚πˆπ€π‹ π–π„ππ’πˆπ“π„ β—βœ¨ΰΌ»κ§‚πŸ‘‡

https://nutrafame.com/Mounjaro

β‡’Main Benefits: Increased Energy, Weight Loss and Appetite Control.

β‡’Side Effects: NA

β‡’Rating: β˜…β˜…β˜…β˜…β˜…

β‡’Where to Buy: β‡’Claim Your Product Now

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk  to major market | Reuters

π‹πˆπŒπˆπ“π„πƒ π“πˆπŒπ„ π’ππ„π‚πˆπ€π‹ πŽπ…π…π„π‘ π‡π”π‘π‘π˜ 𝐔𝐏 𝐀𝐍𝐃 πŽπ‘πƒπ„π‘ ππŽπ–

What Is Mounjaro?

Mounjaro is a prescription medication developed by Eli Lilly, containing the active ingredient tirzepatide. It is a once-weekly injectable drug approved for the treatment of type 2 diabetes and, more recently, for chronic weight management. Mounjaro works by mimicking two hormonesβ€”glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP)β€”to regulate blood sugar levels and suppress appetite .

βš•οΈ Medical Uses

1. Type 2 Diabetes Management

Mounjaro is approved for adults with type 2 diabetes to improve glycemic control. Clinical trials have demonstrated that it can lower HbA1c levels by up to 2.4% over 40 weeks .

2. Weight Management

In addition to diabetes management, Mounjaro has been approved for chronic weight management in adults with obesity (BMI β‰₯30) or overweight (BMI β‰₯27) with at least one weight-related comorbidity. Clinical studies have shown that patients can lose up to 21.8 kg over 72 weeks when combined with diet and exercise .

πŸ’Š How It Works

Tirzepatide is a dual GIP and GLP-1 receptor agonist. By activating both receptors, it enhances insulin secretion, suppresses glucagon release, and slows gastric emptying, leading to improved blood sugar control and reduced appetite .

 

π‹πˆπŒπˆπ“π„πƒ π“πˆπŒπ„ π’ππ„π‚πˆπ€π‹ πŽπ…π…π„π‘ π‡π”π‘π‘π˜ 𝐔𝐏 𝐀𝐍𝐃 πŽπ‘πƒπ„π‘ ππŽπ–

⚠️ Side Effects

Common Side Effects

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Stomach pain

Serious Side Effects

  • Risk of thyroid C-cell tumors (based on animal studies)
  • Pancreatitis
  • Hypoglycemia (especially when used with insulin or sulfonylureas)
  • Acute kidney injury
  • Severe gastrointestinal issues
  • Gallbladder disease

Due to the potential risk of thyroid cancer, Mounjaro is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 .

Mounjaro Weight Loss Clinic Bournemouth - Poole - Beauty Sculpting Room

π‹πˆπŒπˆπ“π„πƒ π“πˆπŒπ„ π’ππ„π‚πˆπ€π‹ πŽπ…π…π„π‘ π‡π”π‘π‘π˜ 𝐔𝐏 𝐀𝐍𝐃 πŽπ‘πƒπ„π‘ ππŽπ–

πŸ§ͺ Clinical Trials and Efficacy

SURPASS Trials (Diabetes)

The SURPASS clinical trial program evaluated the efficacy of tirzepatide in type 2 diabetes management. Results indicated significant reductions in HbA1c levels and body weight compared to placebo and other diabetes medications .

SURMOUNT Trials (Weight Loss)

The SURMOUNT trials assessed the impact of tirzepatide on weight loss. Participants experienced substantial weight reductions, with some losing over 20 kg over 72 weeks, highlighting its potential as an effective weight management therapy .

πŸ§‘β€βš•οΈ Who Should Consider Mounjaro?

Eligible Individuals

  • Adults with type 2 diabetes seeking better blood sugar control
  • Adults with obesity (BMI β‰₯30) or overweight (BMI β‰₯27) with weight-related health conditions.

Contraindications

  • History of pancreatitis
  • Personal or family history of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2
  • Pregnancy or breastfeeding

Mounjaro Australia Cost and Affordability

One of the primary concerns for patients interested in using Mounjaro for weight loss is its cost. As mentioned, Mounjaro Australia cost can be a significant factor in deciding whether to begin treatment. 

On average, the cost of Mounjaro in Australia starts at AUD 395 per month. This price covers the first dose and subsequent doses, but the total cost can increase based on the frequency of use and the required dosage.

Given that Mounjaro Australia prescription is only available privately, patients will need to factor in the cost of consultations with a healthcare provider who can prescribe the medication. The overall monthly expense may therefore reach beyond just the price of the medication itself.

For comparison, other weight loss treatments, such as Ozempic and Wegovy, are similarly priced but offer different mechanisms of action. Both are also GLP-1 agonists, yet Mounjaro stands out due to its dual-receptor approach, which may offer more significant results for certain patients.

However, Mounjaro’s cost can be a barrier for long-term use, particularly for those without the means to cover the ongoing expense. As a result, individuals are encouraged to speak with their healthcare provider about other potential treatments, including lifestyle interventions or surgical options, depending on the severity of their weight condition.

π‹πˆπŒπˆπ“π„πƒ π“πˆπŒπ„ π’ππ„π‚πˆπ€π‹ πŽπ…π…π„π‘ π‡π”π‘π‘π˜ 𝐔𝐏 𝐀𝐍𝐃 πŽπ‘πƒπ„π‘ ππŽπ–

Click Here To Buy Now>>>

https://sites.google.com/view/mounjaro-approved-treat-sleep/home

https://my.tek.com/en/tektalk/oscilloscopes/95f32938-b545-f011-a2da-000d3a33ec9f

https://my.tek.com/en/tektalk/oscilloscopes/97f32938-b545-f011-a2da-000d3a33ec9f

https://my.tek.com/en/tektalk/oscilloscopes/99f32938-b545-f011-a2da-000d3a33ec9f

https://my.tek.com/en/tektalk/oscilloscopes/9ff32938-b545-f011-a2da-000d3a33ec9f

https://my.tek.com/en/tektalk/oscilloscopes/a7f32938-b545-f011-a2da-000d3a33ec9f

https://filmfreeway.com/MounjaroApprovedtoTreatSleepApnoeaAGameChanger

https://filmfreeway.com/FDAGivesGreenLighttoMounjaroforSleepApnoea

https://filmfreeway.com/TirzepatideMounjaroApprovedforSleepApnoeaTreatment

🧠 Psychological and Social Considerations

While Mounjaro has shown efficacy in weight loss and diabetes management, some users have reported psychological side effects, including anxiety and depression. It's essential for healthcare providers to monitor patients for any mood changes and provide appropriate support .

πŸ“° Recent News

  • Dolores Catania's Experience: The reality TV star shared that she gained 20 pounds after Mounjaro's effectiveness diminished, highlighting the importance of individualized treatment plans .
  • Katie Price's Advocacy: Katie Price has been using Mounjaro to manage her son Harvey's obesity, emphasizing the drug's potential benefits when used under medical supervision .

βœ… Conclusion

Mounjaro represents a significant advancement in the treatment of type 2 diabetes and obesity. Its dual-action mechanism offers enhanced efficacy in managing blood sugar levels and promoting weight loss. However, potential side effects and contraindications necessitate careful consideration and consultation with a healthcare provider before initiating treatmen

Challenge By
Ask a question

3 Checkpoints

Welcome to FDA Gives Green Light to Mounjaro for Sleep Apnoea

Unlocks immediately

Checkpoint 1

Unlocks after 1 day

Checkpoint 2
Together is more fun!
Challenges are fun with friends, pass it on.
blurred background

By claiming this, you also unlock

Community access
New updates
Exclusive content
Built with
en